CCL2 and infectious otitis media: AdmiR-126 or batimastat as a single therapy were less effective in suppressing HB-EGF, miR-221, CCL2, and proteases and in inducing miR-126 expression in colon tissues of AOM DSS-treated animals (Fig. 6D–H).